That's beyond my expertise. However, when I listen to the comments from Ms. Wong‑Rieger, with whom I have appeared many times, I realize there's a red tape problem in the way drugs are approved and distributed. It's a major problem, and we have to look into it. I don't think it will alter the bill under study here in committee, but the government definitely has to look into this red tape issue.
